We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Intercept Pharmaceuticals Inc | NASDAQ:ICPT | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 19.00 | 18.66 | 19.02 | 0 | 01:00:00 |
From May 2022 to May 2024
By Colin Kellaher
Intercept Pharmaceuticals Inc. on Friday said it agreed to swap $52.6 million in cash and stock to retire $44.5 million of its 3.5% convertible senior secured notes due 2026.
The Morristown, N.J., biopharmaceutical company said it would pay $22.7 million in cash and issue about 1.65 million shares, worth nearly $29.9 million based on Thursday's closing price of $18.06, in exchange for the notes.
Intercept said the swap, coupled with last month's deal to exchange $406.4 million in cash and stock for $327.9 million of the notes, would reduce the principal balance of the 2026 notes to $127.6 million from $500 million.
Intercept previously said it was making a series of financial moves to improve its capital structure, including reducing its debt and annual interest expenses, as well as potential dilution from the notes' underlying shares.
Write to Colin Kellaher at colin.kellaher@wsj.com
(END) Dow Jones Newswires
September 02, 2022 08:32 ET (12:32 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
1 Year Intercept Pharmaceuticals Chart |
1 Month Intercept Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
